OraSure Technologies Inc
NASDAQ:OSUR
Relative Value
The Relative Value of one
OSUR
stock under the Base Case scenario is
1.593
USD.
Compared to the current market price of 2.775 USD,
OraSure Technologies Inc
is
Overvalued by 43%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
OSUR Competitors Multiples
OraSure Technologies Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
OraSure Technologies Inc
NASDAQ:OSUR
|
200.9m USD | 1.6 | -3.3 | 0.2 | 0.2 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
62.5B USD | 0 | 0 | 0 | 0 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.3T JPY | 10.2 | 37.2 | 26.5 | 31.9 | |
| CH |
|
Alcon AG
SIX:ALC
|
31.8B CHF | 4.1 | 39.6 | 16.3 | 31.7 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
108.5B DKK | 3.9 | 27.2 | 14.2 | 16.9 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
13.7B USD | 3.4 | 33.3 | 17.7 | 23 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.7B GBP | 2.8 | 30.2 | 13.3 | 21.7 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
6.3B USD | 1.3 | -20.7 | 20.1 | 95.1 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
40.9B CNY | 9 | 24.8 | 22.3 | 22.3 | |
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
4.1B CHF | 5.2 | 21.1 | 13.7 | 18.6 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
790.8B JPY | 6.1 | 44.7 | 21 | 28.5 |